ELAB vs NTAP · rev $2.0M vs P/E 28, rev $6.24B
Elevai Labs, Inc. Common Stock (ELAB) versus NetApp Inc (NTAP) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported NTAP revenue for 2026-04-24 was $6.24B. Net income was $1.28B. Revenue was down 5.1% from 2025-04-25 to 2026-04-24. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
ELAB currently screens at market cap $6.5M. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Not investment advice. Open the ELAB and NTAP stock pages for the full models.
Not investment advice.